Community Practice

Eli Lilly's ADHD drug Strattera is now indicated for long-term use.

Aloxi has a new indication for the prevention of postoperative nausea and vomiting (PONV).

CVS Caremark announced a new cosmetics safety policy as part of its Corporate Social Responsibility report.

Medical devices featuring the Carmeda BioActive surface from Medtronic are being recalled because they are made with the contaminated heparin made in China.

A large group of physicians, pharmacists, and patients have pressed Congress to urge FDA to rescind its policy that bars the use of compounded estriol to treat menopause.

A Texas grocery chain is luring moms-to-be with a free prental vitamin offer.

The Public Health Service releases an update to smoking cessation guidelines.

A multidisplinary task force has produced a resource on emergency preparedness for health professionals.

NACDS releases a document stating its position on healthcare reform

Consumer Healthcare Products Association is expanding its Five Moms campaign to help prevent teen cough medicine abuse.

In testimony before a House subcommittee, a homecare organization labels the DMEPOS competitive bidding program as a train wreck.

California Pharmacists Association joins other healthcare provider organizations in suit to halt Medi-Cal budget cuts.

A new pharmacy survey from Consumers Union found wide discrepancies in drug prices and a drop in patient consultations with pharmacists.

PharmaCentra is launching WellTouch First Fill to encourage patients to get their first prescription orders filled.

One lot of a mouthwash from Cardinal Health is being recalled due to bacterial contamination.

The National Community Pharmacists Association joins the United States Chamber of Commerce Global Intellectual Property Center to fight counterfeited and pirated prescription drugs.

Rite Aid is making technological changes to appeal to blind customers.

Wal-Mart has expanded its $4 generic offer to cover discounts for 90-day supplies and OTCs.

McKesson is settling allegations that it violated federal reporting provisions relating to its handling of controlled substances at six of its distribution centers.

In a settlement with the Connecticut attorney general, the Infectious Diseases Society of America agreed to evaluate its Lyme disease guidelines and use of antibiotics.

There has been an "explosion in interest" in pharmacy fraud and abuse (F&A) over the past few months.

Sickle cell disease (SCD) is life-defining. Those with this inherited blood disease never know when a crisis will disrupt their lives. They never know how long SCD is going to interfere with daily living. In many respects SCD determines an individual's quality of life, level of career success, personal finances, and perhaps even longevity-although over the past 30 years improved medical care has significantly improved the lifespan of individuals with SCD.

FDA alerts clinicians to serious infections associated with the use of Enbrel

The Centers for Medicare & Medicaid Services has issued an FAQ that explains about the use of a non-NPI for prescribers who are not covered entities.

In testimony before Congress, an NACDS executive argues that track and trace should not be required.